Milbemycin Oxime Powder

Milbemycin oxime powder is a novel semi-synthetic macrolide antiparasitic drug, prepared by the oximation reaction of milbemycin A3 and A4, fermentation products of Streptomyces hygroscopicus aureola crimosus. It appears as a white to slightly yellow crystalline powder, extremely insoluble in water, but readily soluble in organic solvents such as acetonitrile and anhydrous ethanol. As a broad-spectrum antiparasitic veterinary drug, it holds an important position in pet parasite control due to its unique mechanism of action, high safety profile, and wide range of applications. It is also used in related fields such as biomedical research. If you want to learn more, contact Xi'an Sonwu Biotech Co., Ltd.

Xi'an Sonwu Biotech Co., Ltd is a peptide raw material supplier with peptide technology at its core and an international market orientation. Sonwu is dedicated to the R&D, manufacturing, and worldwide distribution of bioactive peptide and polypeptide ingredients. Sonwu's products are widely applied in multiple fields, including muscle building, beauty and anti-aging, hair health, weight management, nootropics, and pharmaceutical raw materials.

Sonwu's products serve a global clientele, supporting both research and development and industrialization projects. Based on this, Sonwu has received a lot of feedback on Sonwu's products. Therefore, if you need milbemycin oxime, please contact Xi'an Sonwu.

Xi'an Sonwu not only provides large-scale production services but can also provide sample packages to customers first.

Xi'an Sonwu not only supplies high-quality milbemycin oxime, but can also customize products according to customer needs. In addition, Sonwu can provide customized packaging services, including repackaging products according to customer requirements.

1. Customized bottles(size, color, material, style)

2. Customized packaging(vacuum foil packaging, box, drum)

3. Customized label(paint film, matte film, optical mask)

Milbemycin Oxime powder exhibits a highly specific mechanism of action, primarily targeting the nervous and muscular systems of invertebrates (parasites). It has virtually no direct toxicity to mammals, and its core principle revolves around the regulation of chloride ion channels. As an important member of the macrolide class of drugs, it shares a similar mechanism of action with other drugs in its class, but boasts a longer half-life and more sustained effect.
Specifically, after entering the parasite, it exerts a dual effect: firstly, it acts as an agonist of the γ-aminobutyric acid (GABA) neurotransmitter, enhancing the binding force between GABA and its receptors; secondly, it directly binds to glutamate-sensitive chloride ion channels on invertebrate neurons and muscle cells, promoting the continuous influx of chloride ions into the cell, leading to sustained hyperpolarization of the cell membrane and thus blocking the normal transmission of nerve signals. This interference with nerve function paralyzes the parasite, eventually killing it by stopping it from feeding and disrupting its normal metabolism. In some cases, it also prevents parasites from reproducing properly: it can reduce egg production or cause eggs to develop abnormally, helping control the spread of parasites right at the source.
Its low toxicity to mammals stems from the protective effect of the blood-brain barrier: GABA is mainly found in the central nervous system. At the same time, this product cannot cross the blood-brain barrier and will not affect neurotransmission. This is also the key reason why its safety is higher than that of some drugs in the same class.

Compared to traditional antiparasitic drugs, it possesses numerous significant advantages due to its unique characteristics, making it one of the preferred medications in veterinary clinical practice.
Firstly, it has extremely high safety. No harmful effects were observed in pregnant dogs, even when given continuously through delivery, and it had no obvious impact on liver enzyme levels. What's more, it can be safely used in dog breeds with the MDR-1 gene mutation, with very little risk. This is a major advantage compared to similar drugs such as ivermectin.
Secondly, it works against a wide range of parasites and has well-documented effectiveness. It targets and eliminates many internal and external parasites, helping control heartworm in dogs and cats and eliminating intestinal worms like roundworms, hookworms, and whipworms. It also shows strong efficacy against external parasites, such as scabies and demodex mites, achieving comprehensive control both internally and externally.
Thirdly, it is convenient to use and highly compliant. Most milbemycin oxime products on the market are given by mouth, with doses tailored specifically for dogs and cats of different weights. This means pet owners don't have to give the medicine often, making it much easier to stick to the treatment schedule. Furthermore, this drug has no significant interactions with many other antiparasitic drugs and can be used flexibly in combination to broaden its antiparasitic spectrum.

It is primarily used in veterinary medicine, especially for companion animals such as dogs and cats.
In clinical veterinary applications, its core use is for heartworm prevention. It effectively kills heartworm larvae in dogs and cats, preventing them from developing into adults and reducing the risk of heartworm disease. It is particularly suitable for pet control in areas with high heartworm prevalence. Before use, it is recommended to consult a veterinarian to rule out the possibility of adult heartworms in the pet. If infection is confirmed, adult worm treatment should be administered first before using this product for prevention.
Secondly, it is used to control intestinal nematodes and external parasites. It can be used alone or in combination with drugs such as praziquantel and fipronil to treat roundworm, hookworm, and whipworm infections in dogs and cats, as well as external parasite diseases such as mange and demodectic mange, reducing symptoms such as weight loss, diarrhea, and itchy skin caused by parasite infections.
In addition, it can be used in marine coral reef aquariums to remove parasitic crustaceans from corals. However, this use is indiscriminate and will kill beneficial organisms such as shrimp and crabs, so caution is advised. It is important to note that this product is a raw material and must be processed by a professional institution before use. It is not recommended for use in severely weak animals or animals with severely impaired liver or kidney function, unless a veterinarian conducts a risk assessment and determines that the benefits outweigh the risks.

1. Xi'an Sonwu Biotech Co . Ltd has established a complete technology platform covering peptide molecular design, custom synthesis, precision purification, structural identification, and quality control. Strictly adhering to international quality management standards, the company ensures that its peptide raw materials meet the high-end raw material requirements of overseas customers in terms of purity, stability, and batch consistency.

2. Looking to the future, Sonwu will continue to deepen peptide technology innovation, expand Sonwu's global cooperation network, and strive to become a trusted long-term peptide raw material solution partner for international customers.

Besides guaranteeing the product, the most important thing is that customers receive the goods smoothly. So, Xi'an Sonwu offers a range of couriers to meet different needs.

Milbemycin oxime powder is generally well-tolerated, with an extremely low incidence of side effects; most are mild, and serious adverse reactions are rare. Side effects are mainly divided into two categories: mild reactions caused by the drug itself and abnormal reactions under specific circumstances.

The most common mild side effects are mainly digestive and nervous system issues, such as vomiting, diarrhea, loss of appetite, drooling, sleepiness, and low energy. In very rare cases, it may also cause muscle tremors or lack of coordination. These reactions usually occur soon after dosing and generally resolve on their own without special treatment. Some pets may experience mild ocular reactions such as conjunctival congestion and tearing, which generally do not affect continued use of the medication.

If you're looking for a milbemycin oxime supplier, contact Xi'an Sonwu. Click the email, and then you get high-quality products.

Email: sales02@sonwu.com

Hot Tags: milbemycin oxime powder, China milbemycin oxime powder manufacturers, suppliers, factory, pharmaceutical peptides, Piperlongumine Powder, TB500 Powder